Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis

Veterinary Dermatology

Volumn 21, Issue 3, 2010, Pages 233-248

  Olivry, Thierry ^a   DeBoer, Douglas J ^b   Favrot, Claude ^c   Jackson, Hilary A ^d   Mueller, Ralf S ^e   Nuttall, Tim ^f   Prélaud, Pascal ^g  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Dermatology Referral Services   (United Kingdom)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g Clinique Advetia   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CYCLOSPORIN; DERMATOLOGICAL AGENT; GLUCOCORTICOID; TACROLIMUS;

ACUTE DISEASE; ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; BATH; CHRONIC DISEASE; DOG; DOG DISEASE; DRUG COMBINATION; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; TOPICAL DRUG ADMINISTRATION; DERMATITIS, ATOPIC; DOG DISEASES; VETERINARY;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; BATHS; CHRONIC DISEASE; CYCLOSPORINE; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; DOG DISEASES; DOGS; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; TACROLIMUS;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; MALASSEZIA; SIPHONAPTERA (FLEAS); STAPHYLOCOCCUS;

EID: 77954048563     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2010.00889.x     Document Type: Article

References (74)

1. Leung DY, Nicklas RA, Li JT. Disease management of atopic dermatitis: an updated practice parameter. Annals of Allergy, Asthma & Immunology 2004, 93:S1-21.
2. Halliwell R. Revised nomenclature for veterinary allergy. Veterinary Immunology and Immunopathology 2006, 114:2007-8.
3. Marsella R, Samuelson D. Unraveling the skin barrier: a new paradigm for atopic dermatitis and house dust mites. Veterinary Dermatology 2009, 20:533-40.
4. Olivry T, Marsella R, Pucheu-Haston CM. Mechanism of lesion formation in canine atopic dermatitis: 2004 hypothesis. Advances in Veterinary Dermatology 2005, 10-6. Hillier A, Foster AP, Kwochka KW. eds, Vol, 5, Oxford, UK, Blackwell Publishing
5. Carr MN, Torres SM, Koch SN. Investigation of the pruritogenic effects of histamine, serotonin, tryptase, substance P and interleukin-2 in healthy dogs. Veterinary Dermatology 2009, 20:105-10.
6. Griffin CE, DeBoer DJ. The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis. Veterinary Immunology and Immunopathology 2001, 81:255-69.
7. DeBoer DJ, Hillier A. The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Veterinary Immunology and Immunopathology 2001, 81:271-6.
8. Favrot C, Steffan J, Seewald W. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Veterinary Dermatology 2010, 21:23-30.
9. Olivry T, DeBoer DJ, Prélaud P. Food for thought: pondering the relationship between canine atopic dermatitis and cutaneous adverse food reactions. Veterinary Dermatology 2007, 18:390.
10. Hillier A, DeBoer DJ. The ACVD task force on canine atopic dermatitis (XVII): intradermal testing. Veterinary Immunology and Immunopathology 2001, 81:289-304.
11. DeBoer DJ, Hillier A. The ACVD task force on canine atopic dermatitis (XVI): laboratory evaluation of dogs with atopic dermatitis with serum-based ''allergy'' tests. Veterinary Immunology and Immunopathology 2001, 81:277-87.
12. Loflath A, von Voigts-Rhetz A, Jaeger K. The efficacy of a commercial shampoo and whirlpooling in the treatment of canine pruritus - a double-blinded, randomized, placebo-controlled study. Veterinary Dermatology 2007, 18:427-31.
13. DeBoer DJ, Schafer JH, Salsbury CS. Multiple-center study of reduced-concentration triamcinolone topical solution for the treatment of dogs with known or suspected allergic pruritus. American Journal of Veterinary Research 2002, 63:408-13.
14. Bryden SL, Burrows AK, Rème C. Efficacy of a 0.0584% hydrocortisone aceponate spray (cortavance) for the management of pedal pruritus in atopic dogs: a pilot study (abstract). Veterinary Dermatology 2008, 19:40.
15. Nuttall T, Mueller R, Bensignor E. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial. Veterinary Dermatology 2009, 20:191-8.
16. Olivry T, Foster AP, Mueller RS. Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials. Veterinary Dermatology 2010, 21:4-22.
17. Gross TL, Walder EJ, Ihrke PJ. Subepidermal bullous dermatosis due to topical corticosteroid therapy in dogs. Veterinary Dermatology 1997, 8:127-31.
18. Kimura T, Doi K. Dorsal skin reactions of hairless dogs to topical treatment with corticosteroids. Toxicologic Pathology 1999, 27:528-35.
19. Bensignor E, Olivry T. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial. Veterinary Dermatology 2005, 16:52-60.
20. Olivry T, Bizikova P. A systematic review of the evidence of reduced allergenicity and clinical benefit of food hydrolysates in dogs with cutaneous adverse food reactions. Veterinary Dermatology 2010, 21:31-40.
21. Sousa CA, Halliwell REW. The ACVD task force on canine atopic dermatitis (XI): the relationship between arthropod hypersensitivity and atopic dermatitis in the dog. Veterinary Immunology and Immunopathology 2001, 81:233-8.
22. Marsella R, Olivry T, Nicklin C. Pilot investigation of a model for canine atopic dermatitis: environmental house dust mite challenge of high-IgE-producing beagles, mite hypersensitive dogs with atopic dermatitis and normal dogs. Veterinary Dermatology 2006, 17:24-35.
23. Pucheu-Haston CM, Jackson HA, Olivry T. Epicutaneous sensitization with dermatophagoides farinae induces generalized allergic dermatitis and elevated mite-specific immunoglobulin E levels in a canine model of atopic dermatitis. Clinical and Experimental Allergy 2008, 38:667-79.
24. Marsella R, Nicklin C, Lopez J. Studies on the role of routes of allergen exposure in high IgE-producing beagle dogs sensitized to house dust mites. Veterinary Dermatology 2006, 17:306-12.
25. Hill PB, DeBoer DJ. The ACVD task force on canine atopic dermatitis (IV): environmental allergens. Veterinary Immunology and Immunopathology 2001, 81:159-68.
26. Arlian LG, Platts-Mills TAE. The biology of house dust mites and the remediation of mite allergens in allergic disease. Journal of the American Academy of Dermatology 2001, 107:S406-13.
27. Tan BB, Weald D, Strickland I. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996, 347:15-8.
28. Gutgesell C, Heise S, Seubert S. Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. British Journal of Dermatology 2001, 145:70-4.
29. Gotzsche PC, Johansen HK. House dust mite control measures for asthma: systematic review. Allergy 2008, 63:646-59.
30. Raffan E, Lawrence H, Henderson T. Prevalence of the group 1 Dermatophagoides allergens Der p 1 and Der f 1 in homes with no dogs, healthy dogs and Dermatophagoides-sensitized atopic dogs in Liverpool. Veterinary Dermatology 2005, 16:253-60.
31. Swinnen C, Vroom M. The clinical effect of environmental control of house dust mites in 60 house dust mite-sensitive dogs. Veterinary Dermatology 2004, 15:31-6.
32. DeBoer DJ, Marsella R. The ACVD task force on canine atopic dermatitis (XII): the relationship of cutaneous infections to the pathogenesis and clinical course of canine atopic dermatitis. Veterinary Immunology and Immunopathology 2001, 81:239-50.
33. Morris DO, Olivier NB, Rosser EJ. Type-1 hypersensitivity reactions to Malassezia pachydermatis extracts in atopic dogs. American Journal of Veterinary Research 1998, 59:836-41.
34. Nuttall TJ, Halliwell REW. Serum antibodies to Malassezia yeasts in canine atopic dermatitis. Veterinary Dermatology 2001, 12:327-32.
35. Morris DO, DeBoer DJ. Evaluation of serum obtained from atopic dogs with dermatitis attributable to Malassezia pachydermatis for passive transfer of immediate hypersensitivity to that organism. American Journal of Veterinary Research 2003, 64:262-6.
36. Farver K, Morris DO, Shofer F. Humoral measurement of type-1 hypersensitivity reactions to a commercial Malassezia allergen. Veterinary Dermatology 2005, 16:261-8.
37. Morales CA, Schultz KT, DeBoer DJ. Antistaphylococcal antibodies in dogs with recurrent staphylococcal pyoderma. Veterinary Immunology and Immunopathology 1994, 42:137-47.
38. Marsh KA, Ruedisueli FL, Coe SL. Effects of zinc and linoleic acid supplementation on the skin and coat quality of dogs receiving a complete and balanced diet. Veterinary Dermatology 2000, 11:277-84.
39. Baddaky-Taugbøl B, Vroom MW, Nordberg L. A randomized, controlled, double-blinded, multicentre study on the efficacy of a diet rich in fish oil and borage oil in the control of canine atopic dermatitis. Advances in Veterinary Dermatology 2005, 173-87. Hillier A, Foster AP, Kwochka KW. eds, Vol, 5, Oxford, UK, Blackwell Publishing
40. Glos K, Linek M, Loewenstein C. The efficacy of commercially available veterinary diets recommended for dogs with atopic dermatitis. Veterinary Dermatology 2008, 19:280-7.
41. Roudebush P, Bloom PB, Jewell DJ. Consumption of essential fatty acids in selected commercial dog foods compared to dietary supplementation. AAVD/ACVD Meeting 1997, 10-1. Nashville, TN, AAVD & ACVD
42. Roudebush P. Consumption of essential fatty acids in selected commercial dog foods compared to dietary supplementation: an update. Annual Meeting of the American Academy of Veterinary Dermatology & American College of Veterinary Dermatology 2001, Norfolk, VA, American Academy of Veterinary Dermatology & American College of Veterinary Dermatology
43. Olivry T, Marsella R, Hillier A. The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective? Veterinary Immunology and Immunopathology 2001, 81:347-62.
44. Piekutowska A, Pin D, Rème CA. Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs. Journal of Comparative Pathology 2008, 138:197-203.
45. Watson AL, Fray TR, Bailey J. Dietary constituents are able to play a beneficial role in canine epidermal barrier function. Experimental Dermatology 2006, 15:74-81.
46. Bizikova P, Linder KE, Paps JS. Effect of a novel topical diester glucocorticoid spray on immediate and late phase cutaneous allergic reactions in maltese-beagle atopic dogs: a placebo-controlled study. Veterinary Dermatology 2010, 21:70-9.
47. Rème CA, Dufour P. Repeated daily application of 0.0584% hydrocortisone aceponate spray for 8 consecutive weeks in dogs: impact on skin thickness (abstract). Veterinary Dermatology 2008, 19(Suppl. 1):47.
48. Marsella R, Nicklin CF, Saglio S. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. Veterinary Dermatology 2004, 15:294-303.
49. Steffan J, Favrot C, Mueller R. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Veterinary Dermatology 2006, 17:3-16.
50. Paradis M, Scott DW, Giroux D. Further investigations on the use of nonsteroidal and steroidal antiinflammatory agents in the management of canine pruritus. Journal of the American Animal Hospital Association 1991, 27:44-8.
51. Saevik BK, Bergvall K, Holm BR. A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitis. Veterinary Dermatology 2004, 15:137-45.
52. Schmidt V, McEwan N, Volk A. The glucocorticoid sparing efficacy of Phytopica™ in the management of canine atopic dermatitis: a randomised, double blind, placebo controlled trial. Veterinary Dermatology 2010, 21:91-104.
53. Iwasaki T, Hasegawa A. A randomized comparative clinical trial of recombinant canine interferon-gamma (KT-100) in atopic dogs using antihistamine as control. Veterinary Dermatology 2006, 17:195-200.
54. Yasukawa K, Saito S, Kubo T. Low-dose recombinant canine interferon-gamma for treatment of canine atopic dermatitis: an open randomized comparative trial of two doses. Veterinary Dermatology 2010, 21:41-8.
55. Carlotti DN, Madiot G, Ducret J. Use of recombinant omega interferon therapy in canine atopic dermatitis (abstract). Veterinary Dermatology 2004, 15(Suppl. 1):32.
56. Carlotti DN, Boulet M, Ducret J. The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study. Veterinary Dermatology 2009, 20:405-11.
57. Hansson H, Bergvall K, Bondesson U. Clinical pharmacology of clemastine in healthy dogs. Veterinary Dermatology 2004, 15:152-8.
58. Bizikova P, Papich MG, Olivry T. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs. Veterinary Dermatology 2008, 19:348-57.
59. De Vos C, Maleux MR, Baltes E. Inhibition of histamine and allergen skin wheal by cetirizine in four animal species. Annals of Allergy 1987, 59:278-82.
60. Ewert G, Daems T. Traitement de la dermite atopique canine par un copolymere d'acides gras: une etude clinique comparative en double aveugle [treatment of canine atopic dermatitis by a fatty acid copolymer: comparative double blind study]. Pratique Médicale Et Chirurgicale De l'Animal De Compagnie 2001, 36:401-8.
61. Nuttall T, McEwan N. Objective measurement of pruritus in dogs: a preliminary study using activity monitors. Veterinary Dermatology 2006, 17:348-51.
62. Plant JD. Correlation of observed nocturnal pruritus and actigraphy in dogs. Veterinary Record 2008, 162:624-5.
63. Hofmeister EH, Egger CM. Evaluation of diphenhydramine as a sedative for dogs. Journal of the American Veterinary Medical Association 2005, 226:1092-4.
64. Horvath-Ungerboeck C, Thoday KL, Shaw DJ. Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. Veterinary Dermatology 2009, 20:233-42.
65. Hanifin J, Gupta AK, Rajagopalan R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. British Journal of Dermatology 2002, 147:528-37.
66. Berth-Jones J, Damstra RJ, Golsch S. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. British Medical Journal 2003, 326:1367-70.
67. Thaci D, Reitamo S, Gonzalez Ensenat MA. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. British Journal of Dermatology 2008, 159:1348-56.
68. Paller AS, Eichenfield LF, Kirsner RS. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Pediatrics 2008, 122:e1210-8.
69. Bousquet J, Lockey R, Malling H. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Journal of Allergy and Clinical Immunology 1998, 102:558-62.
70. Olivry T, DeBoer DJ, Griffin CE. The ACVD task force on canine atopic dermatitis: forewords and lexicon. Veterinary Immunology and Immunopathology 2001, 81:143-6.
71. Griffin CE, Hillier A. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy. Veterinary Immunology and Immunopathology 2001, 81:363-84.
72. Zur G, White SD, Ihrke PJ. Canine atopic dermatitis: a retrospective study of 169 cases examined at the University of California, Davis, 1992-1998. Part II. Response to hyposensitization. Veterinary Dermatology 2002, 13:103-11.
73. Schnabl B, Bettenay SV, Dow K. Results of allergen-specific immunotherapy in 117 dogs with atopic dermatitis. Veterinary Record 2006, 158:81-5.
74. Loewenstein C, Mueller RS. A review of allergen-specific immunotherapy in human and veterinary medicine. Veterinary Dermatology 2009, 20:84-98.